Objective Capital


	User Name	Password


	back to homepage London Capital Group (LCG.L) – full year trading statement LCG.L Comment by Objective Capital , Jan 03, 2008 Questions? Contact our analyst London Capital said its trading for the year to Dec 31, 2007, is ahead of consensus market expectations and that it continues to experience growth in all its main business divisions. The spread-betting company said it expects to report its full-year results on Feb 20. Objective's view: Market conditions, principally volatility, have favoured the spread betting and foreign-exchange trading businesses for virtually the whole of 2007. After a strong first half it had been expected that LCG would enjoy a good performance for the whole of 2007. While short on detail, this trading statement confirms that 2007 was indeed a good year and by coming in ahead of consensus LCG shows that it has something in reserve. Our expectations for the current year are robust and include full-year contributions for the first time from recent white label deals with Paddy Power and Betfair.


	SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE! Objective, Independent, Experienced. Research you can trust!

	Yes! Subscribe me for the latest stock research from Objective.


	Email address

	My Password

	My information:
	First Name
	Family Name
	Title:

	Job title:
	Job function:
	Industry:
	I am a:
	To receive occasional printed reports complete your mailing address:
	Company Name (if any)
	Address


	City
	Postcode/Zip
	Country


	Please Read Objective's Terms of Use.






	Balkan Resources (Private) - exploring the Perlati copper deposit in Albania Oct 09, 2009 \| Previous Reports Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success Sep 08, 2009 \| Previous Reports Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy Aug 24, 2009 \| Previous Reports Soho Resources (SOH.V) - substantial upgrade to total resource Aug 19, 2009 \| Previous Reports Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential Mar 13, 2009 \| Previous Reports NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown Mar 10, 2009 \| Previous Reports Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns Dec 03, 2008 \| Previous Reports Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential Mar 13, 2009 \| Previous Reports NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown Mar 10, 2009 \| Previous Reports Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns Dec 03, 2008 \| Previous Reports e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons Nov 18, 2008 \| Previous Reports Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy Nov 07, 2008 \| Previous Reports LiDCO (LID.L) - half year results show early signs of being on track Oct 30, 2008 \| Previous Reports OCCASIONAL PAPERS Albania - revisting old frontiers October, 2008 The rise of independent research (IR Magazine) March, 2006 Presentation to 2005 AIM Conference Sept 26, 2005 The Role of Sponsored Research June 22, 2005 Objective's Corporate Brochure July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839